· Updated · Venture Capital Tracker · investment-strategies · 3 min read
Baltimore Startups and VC Firms in 2026: TEDCO, Hopkins Clinical AI, Pearl Diagnostics
Baltimore venture map in 2026 — TEDCO, Latimer, TCP, Maryland Momentum, plus kweliTV, Bayesian Health, Pearl Diagnostics, Inner Logic, and Neurava.
Baltimore is a Johns Hopkins and Maryland commercialization market — clinical AI, diagnostics, medtech wearables, and media — with four local /fund/ profiles, not DC’s defense GP story.
This page maps what we profile.
City hub: /vc/baltimore · All cities: /cities · Fund directory: /directory
What Baltimore is (and is not)
| Baltimore is… | Baltimore is not… |
|---|---|
| Hopkins clinical AI + medtech with TEDCO/Latimer/TCP seed | DC metro HQ defense capital |
| kweliTV, Pearl, Inner Logic, Neurava as living HQ stories | A full Hopkins lab census |
| National Bio + Health capital on real profiles | Philadelphia cell/gene map |
Startups we cover in Baltimore
| Company | What they do | Stage / status | Notable capital | Profile |
|---|---|---|---|---|
| kweliTV | Streaming for global Black diaspora cinema | Pre-seed | a16z TxO Fall 2023 | /startup/kwelitv |
| Bayesian Health | Clinical AI for inpatient risk stratification | Series A ($15M, 2021) | a16z Bio + Health | /startup/bayesian-health |
| Pearl Diagnostics | Noninvasive fungal infection diagnostic (FDA cleared) | Series A ($11.2M, Mar 2026) | Hopkins spinout; SEC filing | /startup/pearl-diagnostics |
| Inner Logic | Simulation/testing for surgical devices | Seed ($11.5M, Jul 2026) | General Catalyst co-lead | /startup/inner-logic |
| Neurava | Wearable epilepsy + SUDEP risk monitoring | Grant + seed | NIH Blueprint $4M (Apr 2026) | /startup/neurava |
Why these names matter
Bayesian Health remains the evidence-bar comp — peer-reviewed sepsis outcomes with Hopkins pedigree; national Bio + Health priced the Series A, but the science was local.
Pearl Diagnostics shows grant-to-priced-round survival: FDA clearance plus $11.2M Series A to launch U.S. sales after a decade of Hopkins science.
Inner Logic is the 2026 Hopkins device-infra raise — simulation before first-in-human, with General Catalyst on the seed syndicate.
Neurava and kweliTV bookend medtech wearables and media — different sectors, same pattern of Baltimore HQ with national capital on larger checks.
Local investors (Baltimore HQ or program)
| Firm | Role | Stages | Profile |
|---|---|---|---|
| TEDCO | Maryland state venture + builder programs | Pre-seed – Series A | /fund/tedco |
| Maryland Momentum Fund | USM late-seed spinouts | Seed | /fund/maryland-momentum-fund |
| Latimer Ventures | Black/Hispanic-led enterprise SaaS | Seed ($1M–$4M) | /fund/latimer-ventures |
| TCP Venture Capital | Propel Baltimore — tech HQ in city | Seed – Series A | /fund/tcp-venture-capital |
How to read this: TEDCO is the broad Maryland first-check umbrella. Latimer fits diverse enterprise SaaS. TCP requires Baltimore City HQ commitment. Momentum fits UMD-system ties more than pure Hopkins spinouts.
National capital Baltimore founders still need
| Firm | Why founders care | Profile |
|---|---|---|
| Andreessen Horowitz | Bio + Health / TxO (kweliTV, Bayesian) | /fund/andreessen-horowitz |
| Define Ventures | Digital health specialist | /fund/define-ventures |
| F-Prime Capital | Healthtech / life sciences | /fund/f-prime-capital |
| General Catalyst | Multi-stage (Inner Logic seed) | /fund/general-catalyst |
Maryland seed vs national health — what differs
| MD seed (TEDCO / Latimer / TCP) | National health Series A+ | |
|---|---|---|
| Best for | First checks, Hopkins intros, city jobs | Clinical AI / device category rounds |
| Check shape | $200k–$1.5M state/seed funds | a16z Bio / GC–class priced rounds |
| Underwrite | Baltimore clinical adjacency + team | National evidence and ownership math |
| Mistake | Treating DC defense funds as default | Pitching a16z Bio with zero clinical proof |
Worked example (illustrative)
Setup: A Baltimore clinical-AI startup publishes peer-reviewed outcomes with a Hopkins-affiliated system and raises a $200k TEDCO builder check plus angel capital.
Move: They close a $15M Series A from national Bio + Health (Bayesian-class).
Punch: Hopkins evidence was the diligence artifact; the syndicate was still national.
When Baltimore is the wrong capital market
- Your buyer is DoD/IC first — start with DC defense hubs.
- You need UMD-system Momentum funding without any USM affiliation.
- You refuse Baltimore City HQ but want TCP Propel capital.
- You invent a full Hopkins portfolio census we have not shipped.
How to use this page
- Read Bayesian Health, Pearl Diagnostics, Inner Logic.
- Local: TEDCO, Latimer, TCP.
- Live hub: /vc/baltimore.
- DC contrast: Washington DC VC firms 2026.
Related reading
Sources
- Company and fund profiles linked above (Venture Capital Tracker JSON)
- Bayesian Series A (Jul 2021, $15M, a16z Bio + Health)
- Pearl Diagnostics Series A (Mar 2026, $11.2M, Technical.ly / SEC)
- Inner Logic seed (Jul 2026, $11.5M, HIT Consultant)
- Neurava NIH award (Apr 2026, $4M, PR Newswire)
- TEDCO venture funds public FAQ (tedcomd.com)
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
